NewsRoom Articles - Page 152 of 154 - PsychedelicNewsWire (PNW)

WednesdaySep 13, 2017 3:58 pm

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) Oral CBD Product to Be Tested by the University of British Columbia

The University of British Columbia (UBC) will conduct a double-blind study of Lexaria’s TurboCBD™ oral ingestion product TurboCBD™ masks foul tastes, protects pharmaceutical ingredients during stomach passage and increases intestinal absorption by 5-10x The UBC study will include 24 volunteers and test their cognitive and cardiovascular function after single doses and after seven days of administration Traditionally, cannabidiol (CBD) is ingested via inhalation, which can harm the lungs, and many edible products contain unwanted sugars or sweeteners. Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has revolutionized oral intake with its TurboCBD™ product. Engineered to increase absorption through the intestinal tract,…

TuesdaySep 12, 2017 3:55 pm

Algae Dynamics Corp. (ADYNF) Collaborating with Prominent Neuroscientist to Research Benefits of Cannabis Oil for Mental Health Disorders

Partnership between Algae Dynamics and Dr. Steven Laviolette focuses on medical benefits of cannabis and hemp oils for various mental health disorders Canada is moving to legalize cannabis throughout the country in 2018, which could radically change research playing field Canadian cannabis oil extraction market projected to reach $1.5 billion by 2020 Algae Dynamics Corp. (OTCQB: ADYNF), a Canadian company focused on the development of proprietary research and products derived from cannabis and hemp oils, has begun a collaborative relationship with one neuroscientist who is looking deep within the brain for answers to some of the world’s most pressing mental…

FridayAug 25, 2017 9:23 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Continues to Deliver Results with its Patented Technology

19 patent applications filed in the United States and internationally (under the Patent Cooperation Treaty), with national filings in 44 countries Collaborative research and development agreement with Canada’s National Research Council to investigate opportunities associated with bioavailability enhancement of certain compounds, including those in cannabinoids, vitamins, NSAIDs and nicotine Out-licenses its patented technology to third party partners, with several deals signed or pending When Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) researchers tackled the issue facing consumers of edible cannabinoids – poor absorption of the product’s bioactive compounds by the body’s gastrointestinal tract – an important statement led the way:…

ThursdayAug 24, 2017 3:22 pm

ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Licensed to Grow Cannabis by Feds in Canada

An early mover in the Canadian cannabis space Serving Canada’s most populous province New funding deal signed for $15 million at $2.25 per share As befits its status as a first mover in the Canadian cannabis space, ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) is racing ahead with plans to supply the medical marijuana needs of Canada’s most populous province. Construction plans at its Kimmett facility in the third quarter of 2017 remain on schedule, and the previously announced plans for a 71,000 square foot phase 1 project have been expanded to 100,000 square feet. The company recently signed a…

FridayAug 04, 2017 3:24 pm

7 Company Updates from this Week to Review

The last week has been quite busy for the global marijuana industry as companies continued to execute and work to create value for shareholders. Although the marijuana industry is comprised of some incredible companies, investors must be selective and focus on the real players. Today we have highlighted 7 developments that marijuana stock investors need to know about. Insys: Second Quarter Revenue Drops 38% Nasdaq-traded Insys Therapeutics (INSY) reported its second quarter financial results today and recorded a 38% drop in revenue when compared to the same quarter last year. Although this biotech cannabis stock has continued to execute, the…

ThursdayJul 27, 2017 9:00 am

Biotech Players Lead the Growth Charge in the Legal Cannabis Market

PsychedelicNewsWire Editorial Coverage: The backbone of medical advancement is biotechnology, an industry wrought with the incredible potential of novel drug R&D, but vulnerable to the risk of stringent regulatory approval processes. Within this volatile market, however, is the cannabis-biotech sub-sector – a market flourishing with opportunity, innovation, and deep roots of medical possibilities. Fueled by an increasing volume of supportive research, cannabis-based biotech companies are addressing large markets of unmet medical need while rising to meet global demand of epic proportion. Included among several companies in the cannabis-biotech sub-sector is Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (LXRP Profile), a…

ThursdayJul 20, 2017 9:00 am

5 Standout Legal Cannabis Companies Worthy of Consideration

PsychedelicNewsWire Editorial Coverage: The legal marijuana market continues to gain momentum, driven by increasing public acceptance and an increasing number of investors looking for viable opportunities on a crowded playing field. According to a recent Gallup poll1, 60 percent of Americans now support the legalization of marijuana. As the playing field continues to grow in diversification and size, some of the most recognizable and frequently seen names are ChineseInvestors.com, Inc. (CIIX) (CIIX Profile), Terra Tech Corp. (TRTC), Medical Marijuana, Inc. (MJNA), Marijuana Company of America, Inc. (MCOA) and CV Sciences, Inc. (CVSI). The market presence of ChineseInvestors.com, Inc. (CIIX) is…

WednesdayJul 12, 2017 3:26 pm

ChineseInvestors.com, Inc. (CIIX) Aims to Become One-Stop-Shop for Chinese MMJ Patients

First online Chinese language cannabidiol (CBD) health products store Yelp-style mobile app for locating dispensaries and discussing cannabis products in the U.S. Investor consultancy and financial news service It appears that since antiquity, the Chinese have been aware of the therapeutic effect of cannabinoids. References in a manuscript with the authoritative title ‘Additional Records of Famous Physicians’, dating from the sixth century AD, point to their use as analgesics for “relieving impediment,” essentially the relief of pain. In a country with such a rich tradition of herbal remedies, cannabinoids have played an important role. Now, generations later, ChineseInvestors.com, Inc. (OTCQB:…

TuesdayJul 11, 2017 1:15 pm

Algae Dynamics Corp. (ADYNF) Changing the Dynamic of Plant Based Therapeutics

Proprietary system for high volume, low cost production of medicinal algae New research on botanical oil products derived from both cannabis and algae Combined health benefits of cannabis and algae create new exclusive market People have always relied on plants as a primary source of medicine and healing. Hundreds of remarkably common plants, herbs, and flowers continue to serve all kinds of important medicinal and health purposes. Various strains of algae offer high concentrations of vitamins, minerals, antioxidants and proteins. Brown algae have been used for weight loss, cancer, fibromyalgia, arthritis, stress, heart disease and high cholesterol. Blue-green algae, scientific studies indicate,…

ThursdayJun 22, 2017 9:00 am

Diverse Opportunities Aplenty for Investors Interested in the Marijuana Market

PsychedelicNewsWire Editorial Coverage: Within the exploding legalized marijuana industry, new innovations and investment opportunities are cropping up all the time; no matter what sector you have interest in, there is likely an investment option to be explored. Among enterprising companies looking for innovative ways to profit within the blossoming marijuana market, SinglePoint, Inc. (SING) (SING Profile), First Bitcoin Capital Corp. (BITCF), Kush Bottles, Inc. (KSHB), Medical Marijuana, Inc. (MJNA) and Solis Tek, Inc. (SLTK) offer diverse opportunities for savvy investors interested in a marijuana-related play. The growth of the legal marijuana market has been bigger and faster than the growth…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000